Literature DB >> 4279268

The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice.

T Yoshiki, R C Mellors, M Strand, J T August.   

Abstract

The use of monospecific antisera for the analysis by radioimmunoassay and immunofluorescence study of two major viral proteins, gp69/71 and p30 of murine leukemia virus, that could be of significance in the pathogenesis of immune complex glomerulonephritis of mice, particularly NZB and B/WF(1) hybrid mice, yielded the following conclusions. A remarkably high concentration of viral envelope glycoprotein, gp69/71, was detected in the spleen and serum of New Zealand mice (NZB, NZW, B/WF(1), and W/BF(1)); the concentration in the spleen was 10-fold greater than that found in AKR mice and 30-fold greater than that present in C57BL/6 mice. The gp69/71 was deposited along with bound immunoglobulins, apparently as an immune complex, in the diseased kidneys of mice, and the glomerular site and extent of deposition of gp69/71 was related to the severity of the glomerulonephritis. This study suggests that the pathogenesis of immune complex glomerulonephritis (and vasculitis) in mice is related to the expression of this specific viral envelope glycoprotein and to the host immune response to this protein.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4279268      PMCID: PMC2139629          DOI: 10.1084/jem.140.4.1011

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Shared group-specific antigen of murine and feline leukemia viruses.

Authors:  G Geering; W D Hardy; L J Old; E de Harven; R S Brodey
Journal:  Virology       Date:  1968-12       Impact factor: 3.616

Review 2.  The immunology and pathology of NZB mice.

Authors:  J B Howie; B J Helyer
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

Review 3.  Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids.

Authors:  R C Mellors
Journal:  Int Rev Exp Pathol       Date:  1966

4.  The inheritance of susceptibility to the Gross leukemia virus in mice.

Authors:  F Lilly
Journal:  Genetics       Date:  1966-03       Impact factor: 4.562

5.  Pathogenesis of the glomerulonephritis of NZB/W mice.

Authors:  P H Lambert; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

6.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

7.  Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1967-07-01       Impact factor: 14.307

8.  Further implication of murine leukemia-like virs in the disorders of NZB mice.

Authors:  R C Mellors; T Aoki; R J Huebner
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

9.  Immunopathology of NZB/BL mice. V. Viruslike (filtrable) agent separable from lymphoma cells and identifiable by electron microscopy.

Authors:  R C Mellors; C Y Huang
Journal:  J Exp Med       Date:  1966-12-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  87 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Increased survival times of New Zealand hybrid mice immunosuppressed by graft-versus-host reactions.

Authors:  D H Lehman; C B Wilson; F J Dixon
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

Review 3.  The lupus-prone BXSB strain: the Yaa gene model of systemic lupus erythematosus.

Authors:  R Merino; L Fossati; S Izui
Journal:  Springer Semin Immunopathol       Date:  1992

4.  Interferon treatment of NZB mice: accelerated progression of autoimmune disease.

Authors:  H Heremans; A Billiau; A Colombatti; J Hilgers; P de Somer
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Evidence that autoimmunity in man is a Mendelian dominant trait.

Authors:  W B Bias; J D Reveille; T H Beaty; D A Meyers; F C Arnett
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

6.  Swan mice: autoimmune mice without xenotropic type C virus production.

Authors:  C Blaineau; S Gisslebrecht; D Piatier; M A Hurot; J P Levy
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

7.  Type C RNA virus-specific antibody in human systemic lupus erythematosus demonstrated by enzymoimmunoassay.

Authors:  R C Mellors; J W Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 8.  T cells of lupus and molecular targets for immunotherapy.

Authors:  S K Datta; A Kaliyaperumal; A Desai-Mehta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

9.  Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector.

Authors:  T Hayashi; Y Noguchi; Y Kameyama
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

10.  Expression of xenotropic-like env RNA sequences in normal DBA/2 and NZB mouse tissues.

Authors:  E J Lee; J Kaminchik; W D Hankins
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.